|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Poruk KE, Pawlik TM and Weiss MJ:
Perioperative management of hilar cholangiocarcinoma. J
Gastrointest Surg. 19:1889–1899. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Donati M, Stang A, Stavrou GA, Basile F
and Oldhafer KJ: Extending resectability of hilar
cholangiocarcinomas: How can it be assessed and improved? Future
Oncol. 15:193–205. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lewis HL, Rahnemai-Azar AA, Dillhoff M,
Schmidt CR and Pawlik TM: Current management of perihilar
cholangiocarcinoma and future perspectives. Chirurgia (Bucur).
112:193–207. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu Y, Peng Y, Wu M, Zhang W, Zhang M, Xie
R, Zhang P, Bai Y, Zhao J, Li A, et al: Oncogene FOXK1 enhances
invasion of colorectal carcinoma by inducing epithelial-mesenchymal
transition. Oncotarget. 7:51150–51162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shi X, Wallis AM, Gerard RD, Voelker KA,
Grange RW, DePinho RA, Garry MG and Garry DJ: Foxk1 promotes cell
proliferation and represses myogenic differentiation by regulating
Foxo4 and Mef2. J Cell Sci. 125:5329–5337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang X, Xiang L, Li Y, Zhao Y, Zhu H,
Xiao Y, Liu M, Wu X, Wang Z, Jiang P, et al: Snail/FOXK1/Cyr61
signaling axis regulates the epithelial-mesenchymal transition and
metastasis in colorectal cancer. Cell Physiol Biochem. 47:590–603.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen F, Xiong W, Dou K and Ran Q:
Knockdown of FOXK1 Suppresses proliferation, migration, and
invasion in prostate cancer cells. Oncol Res. 25:1261–1267. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li P, Yu Z, He L, Zhou D, Xie S, Hou H and
Geng X: Knockdown of FOXK1 inhibited the proliferation, migration
and invasion in hepatocellular carcinoma cells. Biomed
Pharmacother. 92:270–276. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen D, Wang K, Li X, Jiang M, Ni L, Xu B,
Chu Y, Wang W, Wang H, Kang H, et al: FOXK1 plays an oncogenic role
in the development of esophageal cancer. Biochem Biophys Res
Commun. 494:88–94. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li L, Gong M, Zhao Y, Zhao X and Li Q:
FOXK1 facilitates cell proliferation through regulating the
expression of p21, and promotes metastasis in ovarian cancer.
Oncotarget. 8:70441–70451. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu G, Yu W, Jin G, Xu D, Chen Y, Xia T, Yu
A, Fang W, Zhang X, Li Z, et al: PKM2 regulates neural invasion of
and predicts poor prognosis for human hilar cholangiocarcinoma. Mol
Cancer. 14:1932015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiao X, Yu W, Qian J, Chen Y, Wei P, Fang
W and Yu G: ADAM-17 is a poor prognostic indicator for patients
with hilar cholangiocarcinoma and is regulated by FoxM1. BMC
Cancer. 18:5702018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang W, Cui H, Yu D, Chen Y, Wang J and Yu
G: Increased expression of phospho-acetyl-CoA carboxylase protein
is an independent prognostic factor for human gastric cancer
without lymph node metastasis. Med Oncol. 31:152014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu Y, Xie R, Liu X, Wang J, Peng Y, Tang
W, Wu M, Zhang P, Ba Y, Zhao J, et al: Knockdown of FOXK1 alone or
in combination with apoptosis-inducing 5-FU inhibits cell growth in
colorectal cancer. Oncol Rep. 36:2151–2159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie R, Wang J, Liu X, Wu L, Zhang H, Tang
W, Li Y, Xiang L, Peng Y, Huang X, et al: RUFY3 interaction with
FOXK1 promotes invasion and metastasis in colorectal cancer. Sci
Rep. 7:37092017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang P, Tang WM, Zhang H, Li YQ, Peng Y,
Wang J, Liu GN, Huang XT, Zhao JJ, Li G, et al: MiR-646 inhibited
cell proliferation and EMT-induced metastasis by targeting FOXK1 in
gastric cancer. Br J Cancer. 117:525–534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu M, Wang J, Tang W, Zhan X, Li Y, Peng
Y, Huang X, Bai Y, Zhao J, Li A, et al: FOXK1 interaction with FHL2
promotes proliferation, invasion and metastasis in colorectal
cancer. Oncogenesis. 5:e2712016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bergquist A and von Seth E: Epidemiology
of cholangiocarPlentz RR and Malek NP: Clinical presentation, risk
factors and staging systems of cholangiocarcinoma. Best Pract Res
Clin Gastroenterol. 29:245–252. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Plentz RR and Malek NP: Clinical
presentation, risk factors and staging systems of
cholangiocarcinoma. Best Pract Res Clin Gastroenterol. 29:245–252.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang D, Zhang H, Fang Z and Yu G:
Annexin-1 downregulation is associated with clinical outcome in
Chinese patients with hilar cholangiocarcinoma. Eur Surg Res.
45:151–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu WL, Cong WM, Zhang Y, Chen Y, Wang F
and Yu G: Overexpression of ATA1/SLC38A1 predicts future recurrence
and death in Chinese patients with hilar cholangiocarcinoma. J Surg
Res. 171:663–668. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Y, Cha Z, Fang W, Qian B, Yu W, Li W,
Yu G and Gao Y: The prognostic potential and oncogenic effects of
PRR11 expression in hilar cholangiocarcinoma. Oncotarget.
6:20419–20433. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lambert AW, Pattabiraman DR and Weinberg
RA: Emerging biological principles of metastasis. Cell.
168:670–691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen S, Kang X, Liu G, Zhang B, Hu X and
Feng Y: α7-Nicotinic acetylcholine receptor promotes
cholangiocarcinoma progression and epithelial-mesenchymal
transition process. Dig Dis Sci. 64:2843–2853. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang H, Wu X, Xiao Y, Wu L, Peng Y, Tang
W, Liu G, Sun Y, Wang J, Zhu H, et al: Coexpression of FOXK1 and
vimentin promotes EMT, migration, and invasion in gastric cancer
cells. J Mol Med (Berl). 97:163–176. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang J, Liu G, Liu M, Xiang L, Xiao Y, Zhu
H, Wu X, Peng Y, Zhang W, Jiang P, et al: The FOXK1-CCDC43 axis
promotes the invasion and metastasis of colorectal cancer cells.
Cell Physiol Biochem. 51:2547–2563. 2018. View Article : Google Scholar : PubMed/NCBI
|
